Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Changqing Yang
With
Shanghai Changzheng Hospital
Shanghai 10th People's Hospital
The non-invasive 3D-HPS is a newly-developed test to determine vPVPG based on anatomic computed tomographic angiography (CTA) and Doppler ultrasound. In this study, vPVPG is determined by the 3D-HPS.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Proven cirrhosis based on histology or unequivocal clinical, sonographic and laboratory findings
Child-Pugh score \< 9
No visible gastro-esophageal varies by endoscopy
You may not be if
Patients with malignant diseases
Treatment with vasoactive drugs
Prior transjugular intrahepatic portosystemic stent-shunt surgery
Patients with known allergy to iodinated contrast
Treatment with immunosuppressants
Renal sufficiency
Patients with coronary artery diseases, or treated with anticoagulants
Pregnancy
Inability to adhere the follow-up
Any life-threatening disease
Clareo Health | Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
